Imaging blood–brain barrier disruption in neuroinflammation and Alzheimer's disease
The blood–brain barrier (BBB) is the neurovascular structure that regulates the passage of
cells and molecules to and from the central nervous system (CNS). Alzheimer's disease (AD) …
cells and molecules to and from the central nervous system (CNS). Alzheimer's disease (AD) …
Circadian Rhythms of the Blood-Brain Barrier and Drug Delivery
The blood-brain barrier (BBB) is a critical interface separating the central nervous system
from the peripheral circulation, ensuring brain homeostasis and function. Recent research …
from the peripheral circulation, ensuring brain homeostasis and function. Recent research …
[11C]metoclopramide is a sensitive radiotracer to measure moderate decreases in P-glycoprotein function at the blood-brain barrier
S Mairinger, S Leterrier, T Filip… - Journal of Cerebral …, 2024 - journals.sagepub.com
The efflux transporter P-glycoprotein (P-gp) at the blood-brain barrier limits the cerebral
uptake of various xenobiotics. To assess the sensitivity of [11C] metoclopramide to measure …
uptake of various xenobiotics. To assess the sensitivity of [11C] metoclopramide to measure …
Cardiac PET imaging of ATP binding cassette (ABC) transporters: opportunities and challenges
W Liu, P Mossel, V Schwach, RHJA Slart, G Luurtsema - Pharmaceuticals, 2023 - mdpi.com
Adenosine triphosphate binding cassette (ABC) transporters are a broad family of
membrane protein complexes that use energy to transport molecules across cells and/or …
membrane protein complexes that use energy to transport molecules across cells and/or …
Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [11C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain …
L Breuil, N Ziani, S Leterrier, G Hugon, F Caillé… - Pharmaceutics, 2022 - mdpi.com
[11C] metoclopramide PET imaging provides a sensitive and translational tool to explore P-
glycoprotein (P-gp) function at the blood-brain barrier (BBB). Patients with neurological …
glycoprotein (P-gp) function at the blood-brain barrier (BBB). Patients with neurological …
[HTML][HTML] [11C] glyburide PET imaging for quantitative determination of the importance of Organic Anion-Transporting Polypeptide transporter function in the human …
S Marie, L Breuil, Z Chalampalakis… - Biomedicine & …, 2022 - Elsevier
Abstract Organic Anion-Transporting Polypeptides (OATPs) are known to control the liver
uptake of many drugs. Non-hepatic expression of OATPs has been reported although …
uptake of many drugs. Non-hepatic expression of OATPs has been reported although …
Multi-level exploration of glioma biomarkers
J Lin - 2024 - research.rug.nl
Glioma is the most common type of cancer in the central nervous system. Conventional
histopathological classification falls short in capturing the complete pathological spectrum of …
histopathological classification falls short in capturing the complete pathological spectrum of …
Experimental and Pre-clinical Evaluation of Reconstruction Methods in Dynamic PET: Quantitative Characteristics and Effects on Kinetic Modelling
V Turmacu - 2023 - fse.studenttheses.ub.rug.nl
The choice of a reconstruction algorithm in PET affects the accuracy of quantitative
measurements and image interpretation. This study aimed to evaluate the effects of …
measurements and image interpretation. This study aimed to evaluate the effects of …
[PDF][PDF] Dose-response assessment of controlled inhibition of cerebral P-glycoprotein function in vivo using [18F] MC225-PET
L Garcia-Varela, P Mossel, P Aguiar… - in vivo measurements of … - research.rug.nl
Abstract Introduction-The Blood-Brain Barrier P-glycoprotein (P-gp) function can be altered
in several neurodegenerative diseases and due to the administration of different drugs …
in several neurodegenerative diseases and due to the administration of different drugs …